Author:
Courtie Ella,Taylor Matthew,Danks Dominic,Acharjee Animesh,Jackson Thomas,Logan Ann,Veenith Tonny,Blanch Richard J.
Abstract
AbstractTo investigate if retinal thickness has predictive utility in COVID-19 outcomes by evaluating the statistical association between retinal thickness using OCT and of COVID-19-related mortality. Secondary outcomes included associations between retinal thickness and length of stay (LoS) in hospital. In this retrospective cohort study, OCT scans from 230 COVID-19 patients admitted to the Intensive Care Unit (ITU) were compared with age and gender-matched patients with pneumonia from before March 2020. Total retinal, GCL + IPL, and RNFL thicknesses were recorded, and analysed with systemic measures collected at the time of admission and mortality outcomes, using linear regression models, Pearson’s R correlation, and Principal Component Analysis. Retinal thickness was significantly associated with all-time mortality on follow up in the COVID-19 group (p = 0.015), but not 28-day mortality (p = 0.151). Retinal and GCL + IPL layer thicknesses were both significantly associated with LoS in hospital for COVID-19 patients (p = 0.006 for both), but not for patients with pneumonia (p = 0.706 and 0.989 respectively). RNFL thickness was not associated with LoS in either group (COVID-19 p = 0.097, pneumonia p = 0.692). Retinal thickness associated with LoS in hospital and long-term mortality in COVID-19 patients, suggesting that retinal structure could be a surrogate marker for frailty and predictor of disease severity in this group of patients, but not in patients with pneumonia from other causes.
Funder
Surgical Reconstruction and Microbiology Research Centre
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. World Health Organisation. Weekly epidemiological update on COVID-19. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---21-september-2021 (2020).
2. Zaim, S., Chong, J. H., Sankaranarayanan, V. & Harky, A. Covid-19 and Multiorgan Response. Curr. Probl. Cardiol. https://doi.org/10.1016/j.cpcardiol.2020.100618 (2020).
3. Sim, R. et al. Retinal microvascular signs in COVID-19. Br. J. Ophthalmol. 106, 1308–1312 (2021).
4. Tang, Y. et al. Cytokine storm in COVID-19: The current evidence and treatment strategies. Front. Immunol. 11, 1708 (2020).
5. Rovas, A. et al. Microvascular dysfunction in COVID-19: The MYSTIC study. Angiogenesis 24, 145 (2021).